HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.

Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.

$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ bottomed at $0.8; and last at $0.81, down 8%. $EVEREST MED (01952.HK)$ slid 6.3% to $17.9.

$BEIGENE (06160.HK)$ , $SINOPHARM (01099.HK)$ , $LUYE PHARMA (02186.HK)$ , $KINTOR PHARMA-B (09939.HK)$ , $JUNSHI BIO (01877.HK)$ , $HANSOH PHARMA (03692.HK)$ , $ASYMCHEM (06821.HK)$ , $INNOVENT BIO (01801.HK)$ , $WUXI BIO (02269.HK)$ , $WUXI XDC (02268.HK)$ , $GENSCRIPT BIO (01548.HK)$ , $ALPHAMAB-B (09966.HK)$ , $PHARMARON (03759.HK)$ and $AKESO (09926.HK)$ tumbled more than 4%-7%.